CAT-8015: A Second-Generation Pseudomonas Exotoxin A-Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1456
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Anti-Cd22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

Clinical Cancer Research
Cancer ResearchOncology
2010English

Targeting T Cell Malignancies Using CAR-based Immunotherapy: Challenges and Potential Solutions

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Generation of Neutralizing Antipeptide Antibodies to the Enzymatic Domain of Pseudomonas Aeruginosa Exotoxin A

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1998English

Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Multidrug Resistant Pseudomonas Aeruginosa Bloodstream Infection in Adult Patients With Hematologic Malignancies

Haematologica
Hematology
2010English

Targeting the PI3K/AKT/mTOR Signaling Axis in Children With Hematologic Malignancies

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2012English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy